Effect of enzymatic deimination on the conformation of recombinant prion protein

Biochimica et Biophysica Acta - Proteins and Proteomics

Volumn 1794, Issue 8, 2009, Pages 1123-1133

  Young, Duncan S ^a   Meersman, Filip ^a   Oxley, David ^b   Webster, Judith ^b   Gill, Andrew C ^c   Bronstein, Igor ^d   Lowe, Christopher R ^a   Dear, Denise V ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b BABRAHAM INSTITUTE   (United Kingdom)

^c UNIVERSITY OF EDINBURGH   (United Kingdom)

^d KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Amyloid; Arginine modification; Citrulline; Conformational change; Deimination; Post translational modification; Prion protein

Indexed keywords

AMYLOID; ARGININE; CITRULLINE; PRION PROTEIN; PROTEINASE K; RECOMBINANT PROTEIN;

AMINO ACID SUBSTITUTION; ARTICLE; BETA SHEET; CIRCULAR DICHROISM; CONFORMATIONAL TRANSITION; CONTROLLED STUDY; INFRARED SPECTROSCOPY; LIQUID CHROMATOGRAPHY; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN PROCESSING; PROTEIN STRUCTURE; TANDEM MASS SPECTROMETRY;

ANILINO NAPHTHALENESULFONATES; ANIMALS; ARGININE; BIREFRINGENCE; CIRCULAR DICHROISM; CITRULLINE; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ENDOPEPTIDASE K; FLUORESCENT DYES; PRIONS; PROTEIN CONFORMATION; PROTEIN PROCESSING, POST-TRANSLATIONAL; RECOMBINANT PROTEINS; SHEEP; SPECTROSCOPY, FOURIER TRANSFORM INFRARED;

OVIS;

EID: 67349083087     PISSN: 15709639     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbapap.2009.03.013     Document Type: Article

References (50)

1. Prusiner S.B. Molecular biology of prion diseases. Science 252 5012 (1991) 1515-1522
2. Dear D.V., Young D.S., Kazlauskaite J., Meersman F., Oxley D., Webster J., Pinheiro T.J.T., Gill A.C., Bronstein I., and Lowe C.R. Effects of post-translational modifications on prion protein aggregation and the propagation of scrapie-like characteristics in vitro. BBA Proteins and Proteomics 1774 (2007) 792-802
3. Shirai H., Blundell T.L., and Mizuguchi K. A novel superfamily of enzymes that catalyze the modification of guanidino groups. Trends Biochem. Sci. 26 8 (2001) 465
4. Tarcsa E., Marekov L.N., Mei G., Melino G., Lee S.-C., and Steinert P.M. Protein unfolding by peptidylarginine deiminase. Substrate specificity and structural relationships of the natural substrates trichohyalin and filaggrin. J. Biol. Chem. 271 48 (1996) 30709-30716
5. Pritzker L.B., Joshi S., Gowan J.J., Harauz G., and Moscarello M.A. Deimination of myelin basic protein. 1. Effect of deimination of arginyl residues of myelin basic protein on its structure and susceptibility to digestion by cathepsin D. Biochemistry 39 18 (2000) 5374-5381
6. Boggs J.M., Rangaraj G., Koshy K.M., Ackerley C., Wood D.D., and Moscarello M.A. Highly deiminated isoform of myelin basic protein from multiple sclerosis brain causes fragmentation of lipid vesicles. J. Neurosci Res. 57 4 (1999) 529-535
7. Beniac D.R., Wood D.D., Palaniyar N., Ottensmeyer F.P., Moscarello M.A., and Harauz G. Cryoelectron microscopy of protein-lipid complexes of human myelin basic protein charge isomers differing in degree of citrullination. J. Struct. Biol. 129 1 (2000, Feb) 80-95
8. Marquis R.E., Bender G.R., Murray D.R., and Wong A. Arginine deiminase system and bacterial adaptation to acid environments. Appl. Environ. Microbiol. 53 1 (1987, Jan) 198-200
9. McGraw W.T., Potempa J., Farley D., and Travis J. Purification, characterization, and sequence analysis of a potential virulence factor from Porphyromonas gingivalis, peptidylarginine deiminase. Infect. Immun. 67 7 (1999 Jul) 3248-3256
10. Ishigami A., Kuramoto M., Yamada M., and Watanabe K. Senshu Molecular cloning of two novel types of peptidylarginine deiminase cDNAs from retinoic acid-treated culture of a newborn rat keratinocyte cell line. FEBS Lett. 433 1-2 (1998, Aug 14) 113-118
11. Yamakoshi A., Ono H., Nishijyo T., Shiraiwa M., and Takahara H. Cloning of cDNA encoding a novel isoform (type IV) of peptidylarginine deiminase from rat epidermis. Biochim. Biophys. Acta 1386 1 (1998, Jul 28) 227-232
12. Nakashima K., Hagiwara T., Ishigami A., Nagata S., Asaga H., Kuramoto M., Senshu T., and Yamada M. Molecular characterization of peptidylarginine deiminase in HL-60 cells induced by retinoic acid and 1alpha,25-dihydroxyvitamin D(3). J. Biol. Chem. 274 39 (1999, Sep 24) 27786-27792
13. Rus'd A.A., Ikejiri Y., Ono H., Yonekawa T., Shiraiwa M., Kawada A., and Takahara H. Molecular cloning of cDNAs of mouse peptidylarginine deiminase type I, type III and type IV, and the expression pattern of type I in mouse. Eur. J. Biochem. 259 3 (1999, Feb) 660-669
14. Kanno T., Kawada A., Yamanouchi J., Yosida-Noro C., Yoshiki A., Shiraiwa M., Kusakabe M., Manabe M., Tezuka T., and Takahara H. Human peptidylarginine deiminase type III: molecular cloning and nucleotide sequence of the cDNA, properties of the recombinant enzyme, and immunohistochemical localization in human skin. J. Invest. Dermatol. 115 5 (2000, Nov) 813-823
15. Turk E., Teplow D.B., Hood L.E., and Prusiner S.B. Purification and properties of the cellular and scrapie hamster prion proteins. Eur. J. Biochem. 176 1 (1988) 21-30
16. Hope J., Multhaup G., Reekie L.J., Kimberlin R.H., and Beyreuther K. Molecular pathology of scrapie-associated fibril protein (PrP) in mouse brain affected by the ME7 strain of scrapie. Eur. J. Biochem. 172 2 (1988) 271-277
17. Baldwin M.A. Mass spectrometric analysis of prion proteins. Adv. Protein Chem. 57 (2001) 29-54
18. Stahl N., Baldwin M.A., Teplow D.B., Hood L., Gibson B.W., Burlingame A.L., and Prusiner S.B. Structural studies of the scrapie prion protein using mass spectrometry and amino acid sequencing. Biochemistry 32 8 (1993) 1991-2002
19. Prusiner S.B. Prions Proc. Natl. Acad. Sci. U. S. A. 95 23 (1998) 13363-13383
20. Kirby L., Birkett C.R., Rudyk H., Gilbert I.H., and Hope J. In vitro cell-free conversion of bacterial recombinant PrP to PrPres as a model for conversion. J. Gen. Virol. 84 4 (2003) 1013-1020
21. Puchtler H., Sweat F., and Levine M. Method of staining with Congo Red. J. Histochem. Cytochem. 10 (1962) 355-364
22. Klunk W.E., Jacob R.F., and Mason R.P. Quantifying amyloid by Congo Red spectral shift assay. Methods Enzymol. 309 (1999) 285-305
23. McKenzie D., Bartz J., Mirwald J., Olander D., Marsh R., and Acken J. Reversibility of scrapie inactivation is enhanced by copper. J. Biol. Chem. 273 40 (1998) 25345-25347
24. Wadsworrth J.D., Hill A.F., Joiner S., Jackson G.S., Clarke A.R., and Collinge J. Strain-specific prion protein conformation determined by metal ions. Nat. Cell Biol. 1 (1999) 55-59
25. Qin K., Toung D.-S., Yang Y., Chishti M.A., Meng L.-J., Kretzschmar H.A., Yip C.M., Fraser P.E., and Westaway D. Copper(II)-induced conformational changes and protease resistance in recombinant and cellular PrP. Effect of protein age and deamidation. J. Biol. Chem. 275 25 (2000) 19121-19131
26. Soto C., Kascsak R.J., Saborío G.P., Aucouturier P., Wisniewski T., Prelli F., Kascsak R., Mendez E., Harris D.A., Ironside J., Tagliavini F., Carp R.I., and Frangione B. Reversion of prion protein conformational changes by synthetic beta-sheet breaker peptides. Lancet 355 9199 (2000, Jan 15) 192-197
27. Cabiaux V., Brasseur R., Wattiez R., Falmagne P., Ruysschaert J.-M., and Goormaghtigh E. Secondary structure of diptheria toxin and its fragments interacting with acidic liposomes studied by polarized infrared spectroscopy. J. Biol. Chem. 264 (1989) 4928-4938
28. Jang B., Kim E., Choi J.-K., Jin J.-K., Kim J.-l., Ishigami A., Maruyama N., Carp R.I., Kim Y.-S., and Choi E.-K. Accumulation of citrullinated proteins by upregulated peptidylarginine deiminase 2 in brains of scrapie-infected mice. Am. J. Pathol. 173 (2008) 1129-1142
29. Walmsley A.R., Zeng F., and Hooper N.M. The N-terminal region of the prion protein ectodomain contains a lipid raft targeting determinant. J. Biol. Chem. 278 39 (2003) 37241-37248
30. Nunziante M., Gilch S., and Schatzl H.M. Essential role of the prion protein N terminus in subcellular trafficking and half-life of cellular prion protein. J. Biol. Chem. 278 6 (2003) 3726-3734
31. Nandi P.K., and Leclerc E. Polymerization of murine recombinant prion protein in nucleic acid solution. Arch. Virol. 144 9 (1999) 1751-1763
32. Warwicker J. Species barriers in a model for specific prion protein dimerisation. Biochem. Biophys. Res. Commun. 232 2 (1997) 508-512
33. Warwicker J. Modeling a prion protein dimer: predictions for fibril formation. Biochem. Biophys. Res. Commun. 278 3 (2000) 646-652
34. Korth C., Stierli B., Streit P., Moser M., Schaller O., Fischer R., Schulz-Schaeffer W., Kretzschmar H., Raeber A., Braun U., Ehrensperger F., Hornemann S., Glockshuber R., Riek R., Billeter M., Wuthrich K., and Oesch B. Prion (PrPSc)-specific epitope defined by a monoclonal antibody. Nature 390 (1997) 74-77
35. Paramithiotis E., Pinard M., Lawton T., LaBoissiere S., Leathers V.L., Zou W.Q., Estey L.A., Lamontagne J., Lehto M.T., Kondejewski L.H., Francoeur G.P., Papadopoulos M., Haghighat A., Spatz S.J., Head M., Will R., Ironside J., O'Rourke K., Tonelli Q., Ledebur H.C., Chakrabartty A., and Cashman N.R. A prion protein epitope selective for the pathologically misfolded conformation. Nat. Med. 1 (2003) 182
36. Post K., Pitschke M., Schafer O., Wille H., Appel T.R., Kirsch D., Mehlhorn I., Serban H., Prusiner S.B., and Riesner D. Rapid acquisition of beta-sheet structure in the prion protein prior to multimer formation. Biol. Chem. 379 11 (1998) 1307-1317
37. Swietnicki W., Morillas M., Chen S.G., Gambetti P., and Surewicz W.K. Aggregation and fibrillization of the recombinant human prion protein huPrP90-231. Biochemistry 39 2 (2000) 424-431
38. Xiong L.W., Raymond L.D., Hayes S.F., Raymond G.J., and Caughey B. Conformational change, aggregation and fibril formation induced by detergent treatments of cellular prion protein. J. Neurochem. 79 3 (2001) 669-678
39. Zou W.Q., Yang D.S., Fraser P.E., Cashman N.R., and Chakrabartty A. All or none fibrillogenesis of a prion peptide. Eur. J. Biochem. 268 18 (2001) 4885-4891
40. Bolton D.C., McKinley M.P., and Prusiner S.B. Identification of a protein that purifies with the scrapie prion. Science 218 4579 (1982) 1309-1311
41. Prusiner S.B. Novel proteinaceous infectious particles cause scrapie. Science 216 4542 (1982) 136-44.28
42. Prusiner S.B., Groth D.F., Bolton D.C., Kent S.B., and Hood L.E. Purification and structural studies of a major scrapie prion protein. Cell 38 1 (1984) 127-134
43. Meyer R.K., McKinley M.P., Bowman K.A., Braunfeld M.B., Barry R.A., and Prusiner S.B. Separation and properties of cellular and scrapie prion proteins. Proc. Natl. Acad. Sci. U. S. A. 83 8 (1986) 2310-2314
44. Stone L.A., Jackson G.S., Collinge J., Wadsworth J.D., and Clarke A.R. Inhibition of Proteinase K activity by copper(II) ions. Biochemistry 46 1 (2007) 245-252
45. Brown D.R., Hafiz F., Glasssmith L.L., Wong B.-S., Jones I.M., Clive C., and Haswell S.J. Consequences of manganese replacement of copper for prion protein function and proteinase resistance. EMBO J. 19 6 (2000) 1180-1186
46. Brown D.R., and Besinger A. Prion protein expression and superoxide dismutase activity. Biochem. J. 334 Pt 2 (1998) 423-429
47. Lehmann S. Metal ions and prion diseases. Curr. Opin. Chem. Biol. 6 2 (2002) 187-192
48. Caughey B., Brown K., Raymond G.J., Katzenstein G.E., and Thresher W. Binding of the protease-sensitive form of PrP (prion protein) to sulfated glycosaminoglycan and Congo Red [corrected]. J. Virol. 68 4 (1994) 2135-2141
49. Demaimay R., Harper J., Gordon H., Weaver D., Chesebro B., and Caughey B. Structural aspects of Congo Red as an inhibitor of protease-resistant prion protein formation. J. Neurochem. 71 6 (1998) 2534-2541
50. Sc. J. Virol. 80 (2006) 8521-8529